Three disulfide-containing uranyl compounds, [UO 2 (C 7 H 4 O 2 S) 3 ]·H 2 O ( 1 ), [UO 2 (C 7 H 4 O 2 S) 2 (C 7 H 5 O 2 S)] ( 2 ), and [UO 2 (C 7 H 4 O 2 S) 4 ] ( 3 ) have been hydrothermally synthesized. Both in situ disulfide bond formation from 3- and 4-mercaptobenzoic acid (C 7 H 5 O 2 S, MBA) to yield 3,3′- and 4,4′-dithiobisbenzoic acid (C 14 H 8 O 4 S 2, DTBA) and direct assembly with the presynthesized dimeric ligands have been explored. While the starting materials 4-MBA and 4,4′-DTBA both yield 2 via in situ ligand synthesis and direct assembly, respectively, we observe the formation of 1 from the starting material 3-MBA via in situ ligand synthesis and of 3 from the direct assembly of the uranyl cation with 3,3′-DTBA. Concurrently with the synthesis of 1 and 2, we have observed the in situ formation of the crystalline dimeric organic species, 3,3′-DTBA, [(C 7 H 5 O 2 S) 2 ] ( 4 ) and 4,4′-DTBA, [(C 7 H 5 O 2 S) 2 ] ( 5 ). Herein we report the synthesis and crystallographic characterization of 1 − 5, as well as observations regarding the utility of product formation via direct assembly and in situ ligand synthesis.
No takes yet. Share an insight, caveat, or question.
Rowland et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: